By KIM BELLARD A year ago I wrote about disturbing news from the Pew Research Center that trust in science, and in scientists, had fallen since the pandemic. I am slightly relieved to report that a new follow-up study by Pew indicates that trust is up slightly – but still way below where they were…
Acclaim Autism’s COO Ryan Cox shares about his team’s tech journey
Endoscopy, the standard for detecting esophageal precancer, is quite an invasive procedure — so a lot of people who should be screened end up never being tested. Lucid Diagnostics is trying to solve this problem by selling a quick, office-based diagnostic. The post This Pill-Size Diagnostic Seeks to Prevent Thousands of Esophageal Cancer Deaths appeared…
Cortica’s $80 million raise was co-led by Morgan Health and Nexus NeuroTech Ventures and included participation from Autism Impact Fund. The post Cortica Snags $80M to Make Autism Care for Children Less Fragmented appeared first on MedCity News.
In Medicare Physician Fee Schedule Final Rules from recent years, the administration made changes to Medicare payment policies for certain dental services, in addition to other payment and policy changes. The 2023 rule clarified CMS’s interpretation of when medically necessary dental services can be covered and codified certain payment policies, and the 2023, 2024, and…
Los cambios no autorizados en los planes médicos de la Ley de Cuidado de Salud a Bajo Precio (ACA) parecen haberse reducido en las últimas semanas: reguladores federales informaron que hay menos quejas de los consumidores. Los Centros de Servicios de Medicare y Medicaid (CMS), que supervisan ACA, atribuyen esta reducción a las medidas adoptadas…
BridgeBio Pharma claims its drug, Attruby, has an edge over a Pfizer drug as a treatment for cardiomyopathy caused by transthyretin-mediated amyloidosis. But new competition to both products could come soon from Alnylam Pharmaceuticals, now set to receive an FDA decision in this indication by late March. The post FDA Nod for BridgeBio Brings New…
Neal Meropol, M.D., Flatiron’s vice president of research oncology, says that having a broader array of consumers of Flatiron’s real-world data opens up avenues to many different types of research, including on health equity
The Pink Sheet reports on a new international health technology assessment (HTA) body: Health Economics Methods Advisory group (HEMA). The Health Economics Methods Advisory group (HEMA) is a new, independent group of health technology assessment agencies from the US, England and Canada that will work together to develop recommendations on adopting novel health economic methods…
A single source for provider credentialing would involve creating a centralized, continuously updated database of credentialing information that could be accessed and trusted across the healthcare sector. While no such system exists today, it should be the goal, and here’s why. The post The Case for a “Single Source of Truth” in Provider Credentialing appeared…